1 report

Legendre also presented that at ## weeks, ## percent (##/ ##) of non-transplant and ## percent (##/ ##) of transplant patients achieved platelet count normalization compared with ## percent (##/ ##) of non-transplant and ## percent (##/ ##) of

  • Targeted Therapy
  • Vaccine
  • United States
  • Company Operations
  • Alexion Pharmaceuticals, Inc.